Researches Are Developing a Way to Predict Who Will Respond to Checkpoint Inhibitors for Melanoma
Pexels / Pixabay

Researches Are Developing a Way to Predict Who Will Respond to Checkpoint Inhibitors for Melanoma

A recent study, carried out by researchers from the National Cancer Institute (part of the NIH) and several other universities, outlines a potential new method of predicting whether immune checkpoint…

Continue Reading Researches Are Developing a Way to Predict Who Will Respond to Checkpoint Inhibitors for Melanoma
Taking These Two Immunotherapies in Order Could Make MS Symptoms Worse, Report Suggests
qimono / Pixabay

Taking These Two Immunotherapies in Order Could Make MS Symptoms Worse, Report Suggests

According to a story from Multiple Sclerosis News Today, a recent case report suggests that switching from the immunotherapy drug Gilenya to another immunotherapy called Lemtrada could cause a severe…

Continue Reading Taking These Two Immunotherapies in Order Could Make MS Symptoms Worse, Report Suggests

Research Shows a Drug For Transthyretin Amyloid Cardiomyopathy May Significantly Reduce Mortality in Patients

  Pfizer has released the primary results from the Phase 3 clinical trial of tafamidis, an investigational drug being researched as a potential treatment for transthyretin amyloid cardiomyopathy. For more…

Continue Reading Research Shows a Drug For Transthyretin Amyloid Cardiomyopathy May Significantly Reduce Mortality in Patients
Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation
Hans / Pixabay

Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation

According to a story from BioSpace, the gene therapy company Reflection Biotechnologies Ltd. recently announced that the US Food and Drug Administration (FDA) has given Orphan Drug designation to its…

Continue Reading Experimental Drug for Bietti’s Crystalline Dystrophy Gets Orphan Drug Designation
The First Patient Has Been Dosed on a Study of a Drug For Duchenne Muscular Dystrophy
DarkoStojanovic / Pixabay

The First Patient Has Been Dosed on a Study of a Drug For Duchenne Muscular Dystrophy

The Australian biopharmaceutical company Antisense Therapeutics has announced that the first patient has been dosed on a Phase 2 clinical trial of the investigational drug ATL1102, which is being developed…

Continue Reading The First Patient Has Been Dosed on a Study of a Drug For Duchenne Muscular Dystrophy

A Drug Being Developed to Treat Acute Myeloid Leukaemia Has Been Given a Generic Drug Name

The United States Adopted Name Council, which selects simple, new, and informative generic drug names, has approved ‘Onvansertib’ as the generic name for PCM-075. PCM-075 is an investigational drug that…

Continue Reading A Drug Being Developed to Treat Acute Myeloid Leukaemia Has Been Given a Generic Drug Name

New Information Revealed About The Link Between Neurodegenerative Diseases and Aging

According to a story from hms.harvard.edu, a recent study is revealing new information about the connection between aging and neurodegenerative disorders, such as Parkinson's disease, dementia, and amyotrophic lateral sclerosis.…

Continue Reading New Information Revealed About The Link Between Neurodegenerative Diseases and Aging